
Lincomycin Hydrochloride is a premium-grade, white crystalline powder lincosamide antibiotic compound carrying CAS number 7179-49-9. Processed under strict pharmaceutical compliance, this high-purity active substance exhibits exceptional bacterial 50S ribozomal subunit inhibition efficiency and reliable molecular matrix stability, making it an ideal core choice for manufacturing clinical-strength veterinary oral soluble powders, advanced human injectable preparations, and modern microbiological research lines globally.
Excellent crystalline density configuration and outstanding target Gram-positive binding affinity provide a distinct operational edge when engineering modern fast-acting anti-infective formulations. This active pharmaceutical solid operates by reversibly binding to the 50S ribosomal subunit of susceptible micro-organisms to break down pathogen protein synthesis setups, supplying the exact chemical mechanisms required to induce rapid bacteriostatic clearance without altering raw pharmaceutical binder uniformity. It assists compounding engineers in maintaining strict active concentration uniformity across high-speed liquid blending and industrial pouch filling lines, mitigating trace sedimentation risks within automated volumetric dosing machinery. For instance, specialized pharmaceutical facilities incorporate this refined hydrochloride powder as a core active component in targeted veterinary swine dysentery soluble premix production. As a consequence, it maximizes the technical throughput of automated pressurized packaging machinery and continuous quality assurance checks. Consequently, Zyntex coordinates clean room crystallization paths to eliminate downstream polymorph shifts from your factory schedule.
In addition to this, Zyntex coordinates climate-controlled logistics for pilot-scale manufacturing operations and advanced animal health drug development centers. The compound maintains its refined antibiotic integrity under strict storage parameters, preventing moisture-induced chemical breakdown or hydrolytic degradation during automated mechanical blending steps. It advances contemporary medical engineering by providing a thoroughly analyzed, highly predictable broad-spectrum raw material that meets international USP/EP monograph standards. Simultaneously, it remains a critical chemical standard for routine microbial assay zone calibrations and high-performance liquid chromatography (HPLC) compound tracking loops. In brief, our product functions as a dependable chemical foundation, supporting both the performance of commercial clinical batches and the analytical rigor of specialized industrial laboratories.
This high-purity crystalline active antibiotic compound delivers crucial technical value within these four primary industrial sectors:
Primary veterinary hammadde source used for formulating water-soluble therapeutic powders targeted at poultry and swine respiratory treatments. Hence, it directly supports optimal livestock control lines.
Utilized as a high-purity active base to compound professional human or veterinary intramuscular and intravenous injection fluids. Clearly, it is key for uniform dissolving patterns.
Acts as an essential reference active standard for evaluating bacterial resistance lines, assay calibration, and routine diagnostic controls. Resultantly, it guarantees excellent matrix clarity.
Used as a professional granular active component for validating advanced solid oral dose fills and specialized systemic targeted release loops. Specifically, it confirms optimal reaction pathways.
| Parameter | Standard Value |
|---|---|
| Product Name | Lincomycin Hydrochloride Monohydrate |
| Assay / Purity (HPLC) | Min 790 μg per mg (calculated as Lincomycin base) |
| Appearance | White or almost white crystalline powder |
| Specific Rotation | +135° to +145° |
| pH (1 in 20 solution) | 3.0 to 5.5 |
| CAS Number | 7179-49-9 (Monohydrate) / 859-18-7 (Anhydrous) |
⚠️ Safety & Handling (ANTIMICROBIAL SENSITIZER): Lincomycin Hydrochloride is an active linkozamid antibiotic pharmaceutical ingredient. Direct inhalation of fine bulk powder dust, intensive transdermal interaction, or accidental ingestion poses moderate risk factors of systemic gastrointestinal microbiota disruptions, localized respiratory tract irritation, and occupational skin sensitization. Therefore, store strictly inside original hermetically double-sealed industrial containment units located within a cool, exceptionally dry, and properly ventilated pharmaceutical warehouse zone completely isolated from strong alkalizing elements and food packaging flows. Keep processing containers tightly shut when not actively dispensing. Proper personal protective equipment (PPE)—including chemical-resistant nitrile manufacturing gloves, safety protective glasses with side shields, and an approved particulate HEPA filter dust mask—must be worn during all compounding processing phases. Review the Safety Data Sheet (SDS).